Patents by Inventor Akiko Arai

Akiko Arai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7405286
    Abstract: The present invention relates to a new polypeptide and the gene coding therefore, gene being an evolutionarily conserved actin-binding protein, called STARS (striated muscle activator of Rho signalin), that is expressed specifically in cardiac and skeletal muscle cells and is upregulated in response to calcineurin signaling during cardiac hypertrophy. STARS is localized to the thin filament of the sarcomere and to actin stress fibers where it promotes actin bundling. STARS stimulates the transcriptional activity of serum response factor (SRF) through a mechanism that requires actin bundling and Rho kinase activation. STARS provides a mechanism for selectively enhancing the transcriptional activity of SRF in muscle cells and for linking changes in actin dynamics to gene transcription. Also disclosed are methods of using the gene and protein in drug screening and therapy, including, for example, use of the gene in gene therapy to treat cardiovascular disease.
    Type: Grant
    Filed: July 3, 2006
    Date of Patent: July 29, 2008
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Eric Olson, Akiko Arai
  • Publication number: 20070162984
    Abstract: The present invention relates to a new polypeptide and the gene coding therefore, gene being an evolutionarily conserved actin-binding protein, called STARS (striated muscle activator of Rho signalin), that is expressed specifically in cardiac and skeletal muscle cells and is upregulated in response to calcineurin signaling during cardiac hypertrophy. STARS is localized to the thin filament of the sarcomere and to actin stress fibers where it promotes actin bundling. STARS stimulates the transcriptional activity of serum response factor (SRF) through a mechanism that requires actin bundling and Rho kinase activation. STARS provides a mechanism for selectively enhancing the transcriptional activity of SRF in muscle cells and for linking changes in actin dynamics to gene transcription. Also disclosed are methods of using the gene and protein in drug screening and therapy, including, for example, use of the gene in gene therapy to treat cardiovascular disease.
    Type: Application
    Filed: July 3, 2006
    Publication date: July 12, 2007
    Inventors: Eric Olson, Akiko Arai
  • Patent number: 7241472
    Abstract: The method produces a plastic lens with an antireflection film which have the advantages of good adhesion of the antireflection film to any type of hard coat film that underlies it and good abrasion resistance and provides a plastic lens with an antireflection film. The method includes the steps of applying water or an aqueous solution to a plastic lens with an organosilicon compound-containing hard coat film to form a liquid film of water or the aqueous solution on the surface of the hard coat film, then allowing ozone gas to contact with the liquid film to treat the surface of the hard coat film with the ozone gas, and thereafter forming an antireflection film on the surface of the hard coat film through vapor deposition.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: July 10, 2007
    Assignee: Hoya Corporation
    Inventor: Akiko Arai
  • Patent number: 7070957
    Abstract: The present invention relates to a new polypeptide and the gene coding therefore, gene being an evolutionarily conserved actin-binding protein, called STARS (striated muscle activator of Rho signalin), that is expressed specifically in cardiac and skeletal muscle cells and is upregulated in response to calcineurin signaling during cardiac hypertrophy. STARS is localized to the thin filament of the sar comere and to actin stress fibers where it promotes actin bundling. STARS stimulates the transcriptional activity of serum response factor (SRF) through a mechanism that requires actin bundling and Rho kinase activation. STARS provides a mechanism for selectively enhancing the transcriptional activity of SRF in muscle cells and for linking changes in actin dynamics to gene transcription. Also disclosed are methods of using the gene and protein in drug screening and therapy, including, for example, use of the gene in gene therapy to treat cardiovascular disease.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: July 4, 2006
    Assignee: Board of Regents, The University of Texas System
    Inventors: Eric Olson, Akiko Arai
  • Publication number: 20060003094
    Abstract: The method produces a plastic lens with an antireflection film which have the advantages of good adhesion of the antireflection film to any type of hard coat film that underlies it and good abrasion resistance and provides a plastic lens with an antireflection film. The method includes the steps of applying water or an aqueous solution to a plastic lens with an organosilicon compound-containing hard coat film to form a liquid film of water or the aqueous solution on the surface of the hard coat film, then allowing ozone gas to contact with the liquid film to treat the surface of the hard coat film with the ozone gas, and thereafter forming an antireflection film on the surface of the hard coat film through vapor deposition.
    Type: Application
    Filed: April 28, 2005
    Publication date: January 5, 2006
    Applicant: Hoya Corporation
    Inventor: Akiko Arai
  • Publication number: 20040086920
    Abstract: The present invention relates to a new polypeptide and the gene coding therefore, gene being an evolutionarily conserved actin-binding protein, called STARS (striated muscle activator of Rho signalin), that is expressed specifically in cardiac and skeletal muscle cells and is upregulated in response to calcineurin signaling during cardiac hypertrophy. STARS is localized to the thin filament of the sarcomere and to actin stress fibers where it promotes actin bundling. STARS stimulates the transcriptional activity of serum response factor (SRF) through a mechanism that requires actin bundling and Rho kinase activation. STARS provides a mechanism for selectively enhancing the transcriptional activity of SRF in muscle cells and for linking changes in actin dynamics to gene transcription. Also disclosed are methods of using the gene and protein in drug screening and therapy, including, for example, use of the gene in gene therapy to treat cardiovascular disease.
    Type: Application
    Filed: August 20, 2003
    Publication date: May 6, 2004
    Applicant: Board of Regents,The University of Texas System
    Inventors: Eric Olson, Akiko Arai
  • Publication number: 20030127756
    Abstract: The method produces a plastic lens with an antireflection film which have the advantages of good adhesion of the antireflection film to any type of hard coat film that underlies it and good abrasion resistance and provides a plastic lens with an antireflection film. The method includes the steps of applying water or an aqueous solution to a plastic lens with an organosilicon compound-containing hard coat film to form a liquid film of water or the aqueous solution on the surface of the hard coat film, then allowing ozone gas to contact with the liquid film to treat the surface of the hard coat film with the ozone gas, and thereafter forming an antireflection film on the surface of the hard coat film through vapor deposition.
    Type: Application
    Filed: December 11, 2002
    Publication date: July 10, 2003
    Applicant: Hoya Corporation
    Inventor: Akiko Arai